![Eric von Hofe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric von Hofe
Corporate Officer/Principal bei
GENEREX BIOTECHNOLOGY CORPORATION
Profil
Dr. Eric von Hofe is a Vice President at Generex Biotechnology Corp.
and a Chief Executive Officer at CellXLife.
Dr. von Hofe was previously employed as a President & Chief Operating Officer by Affyimmune Therapeutics, Inc., a Director-New Targets by Idera Pharmaceuticals, Inc., a Director-Programs & Operations by Millennium Pharmaceuticals, Inc., a President & Chief Scientific Officer by NuGenerex Immuno-Oncology, Inc., and an Assistant Professor-Pharmacology by University of Massachusetts.
He received his doctorate degree from the University of Southern California.
Aktive Positionen von Eric von Hofe
| Unternehmen | Position | Beginn |
|---|---|---|
| GENEREX BIOTECHNOLOGY CORPORATION | Corporate Officer/Principal | 01.01.2005 |
Ehemalige bekannte Positionen von Eric von Hofe
| Unternehmen | Position | Ende |
|---|---|---|
Affyimmune Therapeutics, Inc.
 Affyimmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in developing engineered immune cells to fight cancer disease | Präsident | - |
| NUGENEREX IMMUNO-ONCOLOGY, INC. | Präsident | - |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Corporate Officer/Principal | - |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Geschäftsführer | - |
Ausbildung von Eric von Hofe
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
27
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Generex Biotechnology Corp.
 Generex Biotechnology Corp. Miscellaneous Commercial ServicesCommercial Services Engages in research, development and commercialization of drug delivery systems & technologies | Commercial Services |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NuGenerex Immuno-Oncology, Inc.
 NuGenerex Immuno-Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapeutic products and vaccines for the treatment of cancer diseases | Health Technology |
University of Massachusetts
University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Affyimmune Therapeutics, Inc.
Affyimmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in developing engineered immune cells to fight cancer disease | Commercial Services |
Wählen Sie MarketScreener 
